Extended Data Fig. 1: Standardized mean differences of covariates in incident GLP-1RA compared to sulfonylureas, DPP4i, SGLT2i, a control composited of equal proportion of incident sulfonylureas, DPP4i, SGLT2i use and a control of participants who received usual care before and after weighting.
From: Mapping the effectiveness and risks of GLP-1 receptor agonists
X-axis: absolute standardized mean difference from 0 to 0.5 where a value larger than 0.5 was plotted as 0.5. A value of less than 0.1 indicates balance was achieved. eGFR, estimated glomerular filtration rate; HbA1c, hemoglobin A1c; ACE/ARB, angiotensin converting enzyme inhibitors/angiotensin-receptor blockers Postop, Postprocedural; GLP-1RA, glucagon-like peptide-1 receptor agonist; DPP4i, dipeptidyl peptidase-4 inhibitor; SGLT2i, sodium-glucose co-transporter-2 inhibitor.
